55.93
Schlusskurs vom Vortag:
$57.65
Offen:
$56.5
24-Stunden-Volumen:
4.62M
Relative Volume:
0.96
Marktkapitalisierung:
$27.83B
Einnahmen:
$163.07B
Nettoeinkommen (Verlust:
$3.31B
KGV:
8.9631
EPS:
6.24
Netto-Cashflow:
$-490.00M
1W Leistung:
-7.92%
1M Leistung:
-5.95%
6M Leistung:
-6.67%
1J Leistung:
-23.09%
Centene Corp Stock (CNC) Company Profile
Firmenname
Centene Corp
Sektor
Branche
Telefon
(314) 725-4477
Adresse
7700 FORSYTH BLVD., ST LOUIS
Vergleichen Sie CNC mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CNC
Centene Corp
|
55.93 | 30.22B | 163.07B | 3.31B | -490.00M | 6.24 |
![]()
UNH
Unitedhealth Group Inc
|
298.11 | 274.85B | 410.06B | 22.11B | 24.86B | 23.88 |
![]()
ELV
Elevance Health Inc
|
377.95 | 90.40B | 183.12B | 5.92B | 3.67B | 25.63 |
![]()
CI
Cigna Group
|
310.86 | 84.71B | 254.47B | 5.03B | 6.01B | 18.06 |
![]()
CVS
Cvs Health Corp
|
62.45 | 78.57B | 378.96B | 5.28B | 5.94B | 4.19 |
Centene Corp Stock (CNC) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-04-08 | Hochstufung | Jefferies | Underperform → Hold |
2025-02-06 | Herabstufung | Argus | Buy → Hold |
2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
2024-12-13 | Hochstufung | UBS | Neutral → Buy |
2024-12-10 | Herabstufung | Jefferies | Hold → Underperform |
2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
2024-03-21 | Herabstufung | Stephens | Overweight → Equal-Weight |
2024-03-06 | Eingeleitet | Barclays | Overweight |
2024-01-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2023-09-05 | Hochstufung | BofA Securities | Underperform → Neutral |
2023-08-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2023-06-20 | Eingeleitet | UBS | Neutral |
2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
2023-03-08 | Herabstufung | Deutsche Bank | Buy → Hold |
2023-02-23 | Herabstufung | JP Morgan | Overweight → Neutral |
2022-12-13 | Herabstufung | BofA Securities | Neutral → Underperform |
2022-09-30 | Eingeleitet | Argus | Buy |
2022-08-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2022-07-28 | Fortgesetzt | Barclays | Overweight |
2022-07-14 | Hochstufung | Jefferies | Hold → Buy |
2022-06-21 | Hochstufung | Credit Suisse | Neutral → Outperform |
2022-06-17 | Eingeleitet | Loop Capital | Buy |
2022-05-27 | Fortgesetzt | Bernstein | Outperform |
2022-05-26 | Herabstufung | BofA Securities | Buy → Neutral |
2022-01-07 | Fortgesetzt | Barclays | Overweight |
2022-01-06 | Fortgesetzt | JP Morgan | Overweight |
2021-12-14 | Eingeleitet | Goldman | Neutral |
2021-12-13 | Bestätigt | BMO Capital Markets | Outperform |
2021-12-13 | Bestätigt | BofA Securities | Buy |
2021-12-13 | Bestätigt | Credit Suisse | Neutral |
2021-12-13 | Bestätigt | Mizuho | Neutral |
2021-12-13 | Bestätigt | Oppenheimer | Outperform |
2021-12-13 | Bestätigt | Stephens | Overweight |
2021-12-13 | Bestätigt | Truist | Buy |
2021-12-13 | Bestätigt | Wells Fargo | Overweight |
2021-12-13 | Bestätigt | Wolfe Research | Outperform |
2021-11-01 | Herabstufung | Citigroup | Buy → Neutral |
2021-09-10 | Eingeleitet | Cowen | Outperform |
2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
2021-05-19 | Eingeleitet | Wells Fargo | Overweight |
2021-05-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
2021-03-10 | Eingeleitet | Mizuho | Neutral |
2021-01-21 | Fortgesetzt | Goldman | Neutral |
2021-01-15 | Herabstufung | Jefferies | Buy → Hold |
2020-09-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
2020-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
2020-02-03 | Fortgesetzt | Evercore ISI | Outperform |
2020-01-28 | Bestätigt | Bernstein | Outperform |
2020-01-06 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
2019-05-10 | Hochstufung | Citigroup | Neutral → Buy |
2019-01-14 | Eingeleitet | Stephens | Overweight |
2018-10-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
2018-07-18 | Fortgesetzt | Citigroup | Neutral |
2017-12-18 | Bestätigt | Jefferies | Buy |
2017-09-13 | Bestätigt | Leerink Partners | Mkt Perform |
2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
2017-05-22 | Herabstufung | JP Morgan | Overweight → Neutral |
2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
2017-03-23 | Herabstufung | Citigroup | Buy → Neutral |
2017-02-08 | Bestätigt | Barclays | Overweight |
2017-02-07 | Fortgesetzt | Cantor Fitzgerald | Overweight |
2017-01-04 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Centene Corp Aktie (CNC) Neueste Nachrichten
St. Louis’ Public Companies Show Strength - stl.news
House Advances Trump's 'One Big Beautiful Bill' After Key Medicaid, Tax, And Border Security Changes - Benzinga
Trump's 'Big Beautiful Bill' Advances: Here's Who Wins And Loses - Benzinga
The Zacks Analyst Blog Highlights UnitedHealth, Centene and Molina Healthcare - TradingView
Trump's 'Big Beautiful Bill' Advances: Here's Who Wins And Loses - Benzinga
Zacks Value Trader Highlights: Centene, Copa and KB Financial - TradingView
Q1 Rundown: Centene (NYSE:CNC) Vs Other Health Insurance Providers Stocks - Yahoo Finance
Cantor Fitzgerald maintains Overweight on Centene shares, $90 target - Investing.com
Insider Stock Buying Reaches US$3.27m On Centene - Yahoo Finance
Screening for Basic Value Stocks - TradingView
Centene shareholders reject climate-related proposals in annual meeting vote - The Business Journals
Sarah London: Leading Women 2025 - Modern Healthcare
Sarah London named Modern Healthcare's Leading Women Vanguard - Modern Healthcare
Centene Corporation (CNC) Announces Results of Annual Meeting - GuruFocus
Centene shareholders vote on key proposals at annual meeting - Investing.com
Should Value Investors Buy Centene (CNC) Stock? - Yahoo Finance
Here's Why Centene (CNC) is a Strong Value Stock - Yahoo Finance
Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer - Yahoo Finance
Why Centene Corporation (CNC) Declined on Tuesday - Insider Monkey
Massive Sell-Offs Just Hit These 10 Stocks Today - Insider Monkey
Delaware First Health and the Centene Foundation Announce Grant Program Open Submission Period - Stock Titan
CNC Q1 Earnings Call: Centene Raises Revenue Guidance Amid Policy Headwinds and Margin Stability - Yahoo Finance
Top Analyst-Rated Healthcare Stocks to Watch Now - MarketBeat
Centene Stock: Analyst Estimates & Ratings - Barchart.com
Centene Corp. stock outperforms competitors on strong trading day - MarketWatch
Interesting CNC Put And Call Options For August 15th - Nasdaq
Centene Corporation (CNC) Reaffirms 2025 Earnings Guidance - GuruFocus
CENTENE SUBSIDIARY ARIZONA COMPLETE HEALTH JOINS SETTLEMENT AGREEMENT TO MOVE FORWARD WITH STATEWIDE LONG-TERM CARE MEDICAID CONTRACT - PR Newswire
Oklahoma Complete Health Offers New and Upgraded Benefits for SoonerSelect Members in 2025 - Stock Titan
New Strong Buy Stocks for May 1st - TradingView
Zacks.com featured highlights Centene, Pediatrix Medical, Pfizer, StoneCo and Banco Santander - TradingView
Centene Corporation (CNC): Among Billionaire Cliff Asness’ Stock Picks with Huge Upside Potential - Insider Monkey
Centene stock price target cut to $61 by Jefferies - Investing.com South Africa
Jefferies Adjusts Price Target for Centene (CNC), Maintains Hold Rating | CNC Stock News - GuruFocus
Centene (CNC) Sees Price Target Reduction by Barclays to $84 | C - GuruFocus
Centene Corporation (CNC): Among Billionaire Israel Englander’s Stock Picks with Huge Upside Potential - Insider Monkey
Forecasting The Future: 4 Analyst Projections For Centene - Benzinga
Centene (CNC) Price Target Reduced Amid Mixed Outlook | CNC Stoc - GuruFocus
Decoding Centene Corp (CNC): A Strategic SWOT Insight - GuruFocus
Centene Corp. stock underperforms Friday when compared to competitors - MSN
Centene Corporation (NYSE:CNC) Q1 2025 Earnings Call Transcript - Insider Monkey
Centene: Q1 Earnings Snapshot - CT Insider
Centene Corp (CNC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Wins ... - Yahoo Finance
Centene Corp (CNC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Wins ... By GuruFocus - Investing.com Canada
Centene Corp (CNC) Q1 2025 Earnings Call Highlights: Strong Reve - GuruFocus
Finanzdaten der Centene Corp-Aktie (CNC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):